Really? And how good are you at determining whether multi-link independent rear suspension in a car is better than a solid axle? How about the merits of unibody versus ladder-on-frame construction? The efficacy of multi-valve, overhead cam engine design versus pushrods?
The average consumer doesn’t have a clue. And yet, cars with these advancements do better in the marketplace. How come? Because there are free market content filters. Consumer Reports, Road and Track, etc.
Or for an example of even more hidden features or defects, how about crash worthiness? Are you capable of determining how your car will fare in an offset front-end collision? I’m betting you’re not. But a car will take a hit in the marketplace if it fares poorly, because the insurance industry has a vested interest here, so it has its own testing laboratories and makes the findings public to drive consumer choice towards safer cars. A five star crash rating from an independent testing lab of good reputation will be plastered all over the car’s advertising, and reviews in Consumer Reports will highlight poor ratings.
You are surrounded by products of high quality, not regulated by government, that you don’t understand. The market has many content filters and mechanisms for ensuring quality and minimizing hidden defects.
Uh, make the risks clear to users and doctors, so they can make informed choices? Let me flip that question around on you: What if Wioxx actually saves tens of thousands of lives, but in a way that is hard to put on the front page of the paper because it lowers cholesterol in diabetes patients and makes it less likely they’ll have heart disease in 20 years, but it kills a dozen people during trials? And just for yucks, let’s say that one of the deaths is a movie star, and the relationship to the drug hits the front pages? Suddenly there’s political pressure on the FDA to ban a drug that saves thousands of people’s lives for every one it kills. Is that a good tradeoff for society? The political calculation is that one highly visible death carries more weight than a hundred lives saved over years of time. Bureaucrats and appointed officials respond to political pressure. No one ever lost their job for banning a substance that might have saved some lives, but they’ll lose it in an instant if they approve a drug that kills people. So the FDA only cares about the risk side of the equation. Long term benefit gets short shrift.
So would it be your contention then that drug makers never voluntarily pull drugs from the market?
Do auto makers ever voluntarily recall cars? Think of the millions it costs them to do that. Then think about why they might make that choice, and it should become clearer that there’s a lot more complexity in the marketplace than your simplistic ‘evil corporations’ model.
How about this from a financial perspective: A drug company releases a drug that it knows could kill people, but it hides the evidence. Someone dies, and sues them for a billion dollars. Now how do the finances work out?
Or how about a drug company that gets known for shoddy testing and releasing dangerous drugs. How many doctors will prescribe their new products in the future? How many sales are worth destroying your reputation for quality?
As a thought experiment to help you mull over these issues, consider the case of the Tylenol killer. A lunatic was randomly placing bottles of poisoned Tylenol on grocery shelves. The makers of Tylenol were in no way at fault here. They could have just said, “Hey, we didn’t do it. Not our fault. Let the police figure it out.” They didn’t do that. Instead, they spent massive amounts of money telling people to stop using their own products. Then they recalled 31 million bottles of Tylenol, which cost more than 100 million dollars in lost sales. When they finally re-introduced Tylenol, they offered $2.50 coupons to every purchaser induce them to buy the product again, which also cost hundreds of millions.
Johnson and Johnson did this for one reason: To protect the reputation of their company and their product. Given the lengths they went to do this, how likely do you think it is that they will casually sell a dangerous drug just to make some short-term profit?
Good reading about the case and Johnson and Johnson’s response to it: The Tylenol Murders
BTW, I should also point out that corrupt companies might find it easier to bribe one regulator than thousands of doctors. Why is it that those who advocate putting immense power in the hands of a few government gatekeepers always assume that they are pure as the driven snow, while simultaneously assuming that public companies will always act malevolently if they aren’t regulated? Especially given the history of corruption in Washington?
Right… What if they are so unconcerned with profits that they make regulations so stringent that they destroy a beneficial industry? Have a look at what’s happening with medical devices like artificial organs, pacemakers, and even artificial limbs - the FDA is regulating them with a heavy hand, and driving companies out of the market. The article I linked to before describes the case of a simple rubber sheet that makes breast exams easier and more likely to detect breast cancer not being available in the U.S. because the FDA is regulating it as a medical device, forcing the maker into long trials it can’t afford. There are dozens of cases like this.